CHEMOTHERAPY
Online ISSN : 1884-5894
Print ISSN : 0009-3165
ISSN-L : 0009-3165
CLINICAL TRIAL OF SULTAMICILLIN IN URINARY TRACT INFECTIONS
NOBUTAKA OHTAHIROAKI MASUDATOMOMI USHIYAMAKAZUHIKO FUJIIMASAHIRO HATAYOSHIO OHMIKAZUO SUZUKIATSUSHI TAJIMAYOSHIO ASO
Author information
JOURNAL FREE ACCESS

1985 Volume 33 Issue Supplement2 Pages 550-560

Details
Abstract
Clinical effect of sultamicillin, a mutual prodrug consisting of ampicillin and sulbactam, was studied in 35 patients with uncomplicated urinary tract infection and in 9 patients with complicated urinary tract infection.
Sultamicillin was orally administered at a dose of 375mg three times a day, or 750mg twice a day. Clinical effects of Sultamicillin on patients with uncomplicated urinary tract infection were excellent in 27 cases, moderate in 8 cases, and overall effectiveness rate was 100%. On patients with complicated urinary tract infection, clinical effects were excellent in 2 cases, moderate in 6 cases, poor in 1 case and overall clinical effectiveness rate was 89%.
During the treatment with Sultamicillin, diarrhea and loose stool were observed in 1 case each, but they were weak enough to continue the treatment.
Content from these authors
© Japanese Society of Chemotherapy
Previous article Next article
feedback
Top